10 companies structurally similar to Vertex Pharmaceuticals Incorporated (VRTX) — identified by peer analysis across revenue dynamics, margin profile, capital efficiency and growth patterns. Not based on sector labels alone.
Companies similar to Vertex Pharmaceuticals Incorporated cluster around comparable structural characteristics, with the strongest visible overlap typically appearing in quality. Examples in this group include Amgen Inc., Regeneron Pharmaceuticals, Inc., Genmab A/S.
| # | Company | Peer score | |
|---|---|---|---|
| #1 |
AMGN · Healthcare
|
63 |
Analysis VRTX vs AMGN |
| #2 |
REGN · Healthcare
|
61 |
Analysis VRTX vs REGN |
| #3 |
GMAB.CO · Healthcare
|
45 |
Analysis VRTX vs GMAB.CO |
| #4 |
VRSK · Industrials
|
75 |
Analysis VRTX vs VRSK |
| #5 |
EW · Healthcare
|
54 |
Analysis VRTX vs EW |
| #6 |
ARM · Technology
|
38 |
Analysis VRTX vs ARM |
| #7 |
IGG.L · Financial Services
|
64 |
Analysis VRTX vs IGG.L |
| #8 |
INCY · Healthcare
|
84 |
Analysis VRTX vs INCY |
| #9 |
ABBV · Healthcare
|
44 |
Analysis VRTX vs ABBV |
| #10 |
QIA.DE · Healthcare
|
62 |
Analysis VRTX vs QIA.DE |
Peer-relative comparison across valuation, quality, growth and stability.
See how Vertex Pharmaceuticals Incorporated ranks within its sector on specific metrics.
Full interactive peer view with similarity scores, compare tool and portfolio integration.
Peer similarity is rule-based and descriptive only. Based on structural analysis of revenue, margins, capital intensity and growth patterns. Not investment advice.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.